…
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey, the United Kingdom, and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company is based in Saint Helier, Jersey.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -0.51M | -0.50M | -0.72M | -0.62M | -0.76M |
| Net income | -0.52M | -0.51M | -0.75M | -0.67M | -0.78M |
| Selling general administrative | 1.04M | 0.99M | 0.93M | 0.86M | 0.88M |
| Gross profit | 0.53M | 0.50M | 0.25M | 0.26M | 0.13M |
| Reconciled depreciation | 0.14M | 0.13M | 0.12M | 0.11M | 0.03M |
| Ebit | -0.50M | -0.49M | -0.69M | -0.59M | -0.75M |
| Ebitda | -0.36M | -0.36M | -0.57M | -0.48M | -0.71M |
| Depreciation and amortization | 0.14M | 0.13M | 0.12M | 0.11M | 0.03M |
| Operating income | -0.50M | -0.49M | -0.69M | -0.59M | -0.75M |
| Other operating expenses | 1.04M | 1.01M | 0.94M | 0.86M | 0.91M |
| Interest expense | 0.01M | 0.01M | 0.03M | 0.03M | 0.02M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | - | 0.03M | 0.03M | 0.02M |
| Net interest income | -0.01M | -0.01M | -0.03M | -0.03M | -0.02M |
| Extraordinary items | - | - | - | - | -0.17M |
| Income tax expense | 0.01M | 0.01M | 0.03M | 0.05M | 0.02M |
| Total revenue | 0.54M | 0.52M | 0.26M | 0.27M | 0.16M |
| Total operating expenses | 1.03M | 0.99M | 0.93M | 0.85M | 0.88M |
| Cost of revenue | 0.00M | 0.02M | 0.01M | 0.00M | 0.03M |
| Total other income expense net | -0.01M | -0.01M | -0.03M | -0.03M | -0.02M |
| Discontinued operations | - | - | - | -0.02M | -0.17M |
| Net income from continuing ops | -0.51M | -0.50M | -0.72M | -0.62M | -0.76M |
| Net income applicable to common shares | - | -0.50M | -0.72M | -0.64M | -0.76M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 1.27M | 1.58M | 1.43M | 1.87M | 1.02M |
| Intangible assets | 0.53M | 0.57M | 0.69M | 0.44M | 0.72M |
| Other current assets | - | 0.08M | 0.06M | 0.43M | 0.07M |
| Total liab | 0.56M | 0.39M | 0.36M | 0.21M | 0.25M |
| Total stockholder equity | 0.71M | 1.19M | 1.07M | 1.66M | 0.76M |
| Other current liab | 0.50M | 0.34M | 0.27M | 0.14M | 0.18M |
| Common stock | 1.83M | 1.83M | 1.70M | 1.40M | 1.20M |
| Capital stock | 1.83M | 1.83M | 1.70M | 1.40M | 1.20M |
| Retained earnings | -22.18M | -21.67M | -21.16M | -20.45M | -19.81M |
| Good will | 0.22M | 0.21M | 0.20M | 0.13M | 0.20M |
| Cash | 0.31M | 0.73M | 0.48M | 0.87M | 0.03M |
| Total current liabilities | 0.56M | 0.39M | 0.36M | 0.21M | 0.25M |
| Net debt | -0.25M | -0.67M | -0.39M | -0.81M | 0.03M |
| Short term debt | 0.06M | 0.06M | 0.09M | 0.06M | 0.06M |
| Short long term debt | 0.06M | 0.06M | 0.09M | 0.06M | 0.06M |
| Short long term debt total | 0.06M | 0.06M | 0.09M | 0.06M | 0.06M |
| Other stockholder equity | 21.06M | 21.03M | 20.53M | 20.71M | 19.38M |
| Property plant equipment | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Total current assets | 0.51M | 0.81M | 0.54M | 1.30M | 0.09M |
| Net tangible assets | - | 0.42M | 0.18M | 1.09M | -0.16M |
| Net receivables | 0.15M | 0.04M | 0.04M | 0.02M | 0.04M |
| Accounts payable | 0.01M | 0.39M | 0.01M | 0.01M | 0.01M |
| Accumulated other comprehensive income | - | - | -0.01M | -0.01M | -0.01M |
| Common stock total equity | - | - | 1.70M | 1.40M | 1.20M |
| Non currrent assets other | - | - | - | 0.57M | 0.92M |
| Non current assets total | 0.76M | 0.78M | 0.89M | 0.57M | 0.92M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -0.04M | -0.06M | -0.03M | -0.12M | -0.14M |
| Change to liabilities | - | 0.03M | 0.13M | -0.06M | 0.10M |
| Total cashflows from investing activities | - | -0.06M | -0.03M | -0.12M | -0.14M |
| Net borrowings | - | - | 0.04M | 0.04M | 0.04M |
| Total cash from financing activities | - | 0.59M | 0.07M | 1.48M | 0.45M |
| Change to operating activities | - | - | - | - | 0.04M |
| Net income | -0.51M | -0.50M | -0.72M | -0.64M | -0.76M |
| Change in cash | -0.41M | 0.25M | -0.39M | 0.84M | -0.36M |
| Begin period cash flow | 0.73M | 0.48M | 0.87M | 0.03M | 0.39M |
| End period cash flow | 0.31M | 0.73M | 0.48M | 0.87M | 0.03M |
| Total cash from operating activities | -0.37M | -0.29M | -0.42M | -0.52M | -0.68M |
| Issuance of capital stock | 0.00M | 0.59M | 0.03M | 1.05M | 0.52M |
| Depreciation | 0.14M | 0.13M | 0.12M | 0.11M | 0.03M |
| Other cashflows from investing activities | - | - | - | - | -0.10M |
| Change to account receivables | - | -0.01M | -0.04M | 0.04M | -0.07M |
| Sale purchase of stock | - | - | 0.03M | 1.05M | 0.52M |
| Other cashflows from financing activities | -0.04M | -0.06M | 0.04M | 0.43M | -0.06M |
| Change to netincome | - | 0.06M | 0.08M | 0.02M | 0.01M |
| Capital expenditures | 0.04M | 0.06M | 0.03M | 0.12M | 0.03M |
| Change in working capital | 0.05M | 0.02M | 0.09M | -0.02M | 0.04M |
| Stock based compensation | 0.01M | 0.01M | 0.03M | 0.03M | 0.01M |
| Other non cash items | -0.06M | 0.01M | 0.03M | -0.01M | - |
| Free cash flow | -0.41M | -0.35M | -0.45M | -0.64M | -0.72M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IQAI IQ-AI Ltd |
-0.10 12.73% |
0.72 | - | - | 14.84 | 20.07 | 15.11 | -22.48 |
| CRW Craneware Plc |
2.00 0.18% |
1088.00 | 29.63 | 11.26 | 2.36 | 1.84 | 2.89 | 9.61 |
| OPT Optima Health plc |
- -% |
243.50 | 15.04 | 13.59 | 1.42 | 0.96 | 1.52 | 10.54 |
| DXRX Diaceutics PLC |
1.50 0.75% |
200.50 | - | 178.57 | 4.07 | 3.51 | 3.53 | 35.21 |
| KOO Kooth plc |
- -% |
189.50 | 16.06 | 11.38 | 0.64 | 1.42 | 0.35 | 2.52 |
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey, the United Kingdom, and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company is based in Saint Helier, Jersey.
| Name | Title | Year Born |
|---|---|---|
| Mr. Trevor Edward Brown M.B.A. | CEO & Director | 1946 |
| Mr. David W. J. Smith | Chief Operating Officer | NA |
| Donald Reid | Sec. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.